ZygoFix Overview
ZygoFix has developed a screwless implant for spinal fusion, a surgical procedure commonly prescribed for the treatment of severe back pain. The companys zLOCK miniature 3D printed implant utilizes the spines own anatomy for spinal stability, as opposed to the external screw-based bridge. The simple, straightforward, minimally invasive procedure eliminates the risks associated with miss-screwing and can be performed in an outpatient setting. The zLOCK Facet Fusion System was selected as one of the Ten Best New Spine Technologies for 2017 by Orthopedics This Week (USA). ZygoFix is a part of The Trendlines Group.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Spinal fusion doesn't have to be such a pain in the back, says ZygoFix | CTech
ZygoFix, a medical device company, has developed a small chip device that can provide a more effective stabilization solution for chronic back pain. The device is less invasive and can be implanted into the joint to stabilize it from within. This allows for a simpler outpatient procedure that benefits the healthcare system, surgeons, and patients. The CEO, Ofer Levy, explains that the traditional method of spinal fusion involves placing screws and a rigid rod externally, while ZygoFixs device offers a simpler and more efficient alternative. The article includes a video interview with Levy discussing the device.
CustomersPartners
growth-positive
ZygoFix Receives CE Clearance for its zLOCK Spinal Fusion System
ZygoFix has obtained CE mark for its zLOCK Spinal Fusion System, a minimally invasive screwless spinal fusion system for the treatment of chronic back pain. The system utilizes the spines anatomy for stability and eliminates risks associated with improperly placed screws. ZygoFix plans to conduct a multi-center pivotal study in the EU to collect further clinical data. The company was founded in 2017 and has received funding from The Trendlines Group, Israel Innovation Authority, Agriline, and additional investors.
CustomersInvestment
growth-positive
ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel
ZygoFix, a portfolio company of The Trendlines Group, has completed a $2 million funding round for its alternative solution to spinal fusion for severe back pain. The funding will be used for further clinical studies, enhancing the system implant and tools, and regulatory clearance. ZygoFixs zLOCK implant provides spinal stability and fusion, replacing complex screw stabilization. The implants patented bendable features allow for adjustment to specific joints shapes during insertion. The first clinical case in Israel was successful, and the ongoing study in Hungary has shown a reduction in pain and increase in quality of life for patients. ZygoFix was founded in 2017 and received initial investment from Trendlines and further funding from the Israel Innovation Authority.
Investment
growth-positive
First-in-Human: ZygoFix's Spinal Facet Joint Fixation System
ZygoFix Ltd., a spine company based in Misgav, Israel, has successfully conducted a human clinical study for its zLOCK spinal facet joint fixation system. The study showed positive results, with a significant reduction in pain for the patient. The zLOCK implant is designed to stabilize the spine segment using a combination of rigid and flexible elements. It is less invasive than traditional pedicle screw procedures and has a lower risk of causing nerve root injury. The CEO of ZygoFix, Ofer Levy, revealed plans to expand the clinical study and discuss the registration process with the FDA in the coming year.
CustomersExpand
growth-positive
Successful First in Human for ZygoFix's Spinal Facet Joint Fixation System
ZygoFix Ltd., a portfolio company of The Trendlines Group Ltd., has announced the successful start of a first in human clinical study for its zLOCK spinal facet joint fixation system. The study involved several procedures and a 6-month follow-up of the first case, which showed significant pain reduction. The zLOCK implant is a miniature facet fusion cage designed to stabilize the spine segment. It offers a less invasive alternative to traditional pedicle screw procedures and has the potential for better long-term stabilization. ZygoFix aims to simplify and improve spinal fusion procedures with its unique design.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $8.96M |
| Last funding | $6.11M |
| Stage | Seed |
| Rounds | 4 |
| Investors | 6 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | www.zygofix.com/ |
Locations
Misgav Regional Council, Israel
Photos & Videos
3 item(s)
